Abstract
The critical role of the innate immune system has been confirmed in driving local and systemic inflammation and the cytokine release storm in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This dysregulated immune response is focused on interferon (IFN) and complement activation, which are crucial for the development of metabolic inflammation, local lung tissue damage, and systemic multi-organ failure. IFNs control viral infections by inducing expression of IFN-stimulated genes (ISGs) that restrict distinct steps of viral replication. Therefore, in this review article, we propose the mechanism of SARS-CoV-2-associated acute respiratory disease syndrome, and assess treatment options by considering IFNs and by targeting IFN-antagonist SARS-CoV-2 virulent gene products. Furthermore, we elaborate on the mechanism of the amplified complement-mediated inflammatory cytokine storm, and propose an antiviral and immunotherapeutic strategy against coronavirus disease 2019 (COVID-19).
| Original language | English |
|---|---|
| Pages (from-to) | 507-518 |
| Number of pages | 12 |
| Journal | Journal of Inflammation Research |
| Volume | 2020 |
| Issue number | 13 |
| DOIs | |
| Publication status | Published - 9 Sept 2020 |
| Externally published | Yes |
Keywords
- Complement
- Cytokines
- IFNs
- Innate immune system
- SARS-CoV-2
- Virulent